IL6 and breast carcinoma: Another TME component is MSC which protect ovarian cancer cells from carboplatin-induced apoptosis through inhibition of caspase activation, however, secrete high levels of IL-6 and IL-8 contributing to chemoresistance in breast cancer (105).